Subscribe to RSS
DOI: 10.1055/s-2006-948182
An Environmentally Friendly Synthesis of Functionalized Indanes Using Electrochemical Cyclization of ortho-Halo-Substituted Homoallyl Ethers and Esters
Publication History
Publication Date:
09 August 2006 (online)
Abstract
The electrochemical cyclization of a series of ortho-halo-substituted homoallyl ethers and esters to functionalized indanes catalyzed by Ni(II) catalyst precursors derived from Ni(cyclam)Br2, (cyclam = 1,4,8,11-tetraazacyclotetradecane) and Ni(tmc)Br2, (tmc = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane) is reported. The starting homoallyl ethers were synthesized using either a one-pot method for allylation of aldehydes or by direct allylation of the corresponding acetals using bismuth triflate as a catalyst. The remarkably low toxicity, low cost and ease of handling of bismuth salts coupled with the mild nature of the electrochemical procedure makes this approach to indane synthesis especially environmentally friendly and attractive.
Key words
bismuth - electrochemical cyclization - homoallyl ethers - indanes - Ni(II) cyclam
-
1a
Giese B. In Radicals in Organic Synthesis: Formation of Carbon-Carbon Bonds Pergamon Press; Oxford: 1986. -
1b
Stork G. In Radical-Mediated Cyclization Processes - A Goal for Synthetic EfficiencyBartmann W.Trost BM. Verlag Chemie; Basel: 1984. -
2a
Majumdar KC.Basu PK.Mukhopadhyay PP. Tetrahedron 2004, 60: 6239 -
2b
Davies AG. Organotin Chemistry 2nd ed.: Wiley and Sons; London: 2004. - 3
Duñach E.Franco D.Olivero S. Eur. J. Org. Chem. 2003, 1605 - 4
Olivero S.Rolland J.-P.Duñach E. Organometallics 1998, 17: 3747 -
5a
Hong B.-C.Sarshar S. Org. Prep. Proced. Int. 1999, 1: 1 -
5b
Wickens P,Cantin L.-D,Chuang C.-Y,Dai M,Hentemann MF,Kumarasinghe E,Liang SX,Lowe DB,Shelekhin TE,Wang Y,Zhang C,Zhang H.-J, andZhao Q. inventors; PCT Int. Appl., WO 2004011446. -
5c
Sekiguchi T,Nakagawa S, andFujikura Y. inventors; JP 03044337. -
5d
Meakins SE, andMotion KR. inventors; Eur. Pat. Appl., EP 393742. -
5e
Frank WC. inventors; USA, US 93-79008. -
5f
Ohnuma H,Fujikura Y,Fujita M, andToi N. inventors; Eur. Pat. Appl., EP 385497. -
5g
Sprecker MA,Weiss RA,Belko RP, andMolner EA. inventors; USA, US 6342612. -
6a
Wickens P,Cantin L.-D,Chuang C.-Y,Dai M,Hentemann MF,Kumarasinghe E,Liang SX,Lowe DB,Shelekhin TE,Wang Y,Zhang C,Zhang H.-J, andZhao Q. inventors; PCT Int. Appl., WO 2004011446. -
6b
Sekiguchi T,Nakagawa S, andFujikura Y. inventors; JP 03044337. -
6c
Meakins SE, andMotion KR. inventors; Eur. Pat. Appl., EP 393742. -
6d
Frank WC. inventors; USA, US 93-79008. - 7
Anzalone PW.Baru AR.Danielson EM.Hayes PD.Nguyen MP.Panico AF.Smith RC.Mohan RS. J. Org. Chem. 2005, 70: 2091 -
8a
Reglinski J. In Chemistry of Arsenic, Antimony and BismuthNorman NC. Blackie Academic and Professional; New York: 1998. p.403-440 -
8b
Organobismuth Chemistry
Suzuki H.Matano Y. Elsevier; Amsterdam: 2001. -
8c
Leonard NM.Wieland LC.Mohan RS. Tetrahedron 2002, 58: 8373 -
8d
Antoniotti S. Synlett 2003, 1566 -
8e
Gaspard-Iloughmane H.Le Roux C. Eur. J. Org. Chem. 2004, 2517 - 9
Bosnich B.Tobe ML.Webb GA. Inorg. Chem. 1965, 4: 1109 - 10
Gosden C.Healy KP.Pletcher D. J. Chem. Soc., Dalton Trans. 1978, 8: 972 - 11
Duñach E.Esteves AP.Medeiros MJ.Olivero S. New J. Chem. 2005, 4: 633 - 12
Armstrong DW.Gahm KH.Chang LW. Microchem. J. 1997, 57: 149 - 13
Izumi T.Murakami S. J. Chem. Technol. Biotechnol. 1994, 60: 23 - 14
Miura M.Yoshida M.Nojima M.Kusabayashi S. J. Chem. Soc., Perkin Trans. 1 1982, 1: 79 - 15
Yadav JS.Subba Reddy VB.Srihari P. Synlett 2001, 673 - 16
Watahiki T.Akabane Y.Mori S.Oriyama T. Org. Lett. 2003, 5: 3045 - 17
Hosomi A.Masahiko E.Sakurai H. Chem. Lett. 1976, 941 - 18
Aggarwal VK.Vennall GP. Synthesis 1998, 1822 -
19a
Compound 1a (Method A, 76%): 1H NMR: δ = 1.79 (t, 3 H, J = 7.2 Hz), 2.42-2.46 (m, 2 H), 3.35-3.39 (m, 2 H), 4.72-4.73 (m, 1 H), 5.01-5.10 (m, 2 H), 5.83-5.89 (m, 1 H), 7.25-7.52 (m, 4 H). 13C NMR (12 peaks): δ = 14.8, 40.7, 64.1, 79.4, 116.4, 122.5, 127.1, 127.2, 128.2, 132.1, 134.2, 141.1. HRMS: m/e calcd for C12H15BrO: 254.0306 [M]; found: 253.0231 [M - 1].
-
19b
Compound 1b (Method A, 88%): 1H NMR: δ = 2.45 (m, 2 H), 3.24 (s, 3 H), 4.65 (dd, 1 H), 5.07 (m, 2 H), 5.85 (dp, 1 H), 7.42 (m, 4 H). 13C NMR (11 peaks): δ = 41.0, 50.9, 81.7, 117.0, 123.1, 127.5, 127.6, 128.8, 132.6, 134.4, 140.7. HRMS: m/e calcd for C11H13BrO: 240.0150 [M]; found: 239.0066 [M - 1].
-
19c
Compound 1c (Method D, 27%): 1H NMR: δ = 2.09 (s, 3 H), 2.55-2.60 (m, 2 H), 5.04-5.10 (t, 2 H, J = 6.43 Hz), 5.72-5.78 (m, 1 H), 6.12-6.15 (dd, 1 H, J = 7.67, 2.73 Hz), 7.09-7.54 (m, 4 H). 13C NMR (12 peaks): δ = 21.0, 39.5, 73.8, 118.1, 122.0, 127.2, 127.4, 129.0, 132.7, 132.9, 139.6, 169.7. HRMS: m/e calcd for C12H13BrO2: 268.0099 [M]; found: 268.0098 [M - 1].
-
19d
Compound 1d (Method C, 27%): 1H NMR: δ = 2.48 (t, 2 H, J = 6.9 Hz), 4.28-4.48 (dd, 2 H), 4.86 (t, 1 H, J = 6.18 Hz), 5.02-5.10 (m, 2 H), 5.81-5.94 (m, 1 H), 7.12-7.55 (m, 9 H). 13C NMR (15 peaks): δ = 41.2, 70.9, 79.6, 117.1, 123.1, 127.6, 127.7 (2 peaks), 127.9, 128.3, 128.9, 132.7, 134.5, 138.2, 141.0. HRMS: m/e calcd for C17H17BrO: 316.0463 [M]; found: 315.0381 [M - 1].
-
19e
Compound 1e (Method C, 77%): 1H NMR: δ = 1.18 (t, 3 H, J = 7.18 Hz), 2.42-2.46 (m, 2 H), 3.36-3.39 (m, 2 H), 4.76-4.80 (m, 1 H), 5.00-5.10 (m, 2 H), 5.79-5.92 (m, 1 H), 7.16-7.50 (m, 4 H). 13C NMR (12 peaks): δ = 14.7, 40.6, 64.1, 77.1, 116.3, 126.5, 126.9, 127.8, 128.8, 132.3, 134.2, 139.6. HRMS: m/e calcd for C12H15ClO: 210.0811 [M]; found: 209.0740 [M - 1].
-
19f
Compound 1f (Method B, 81%): this compound has been reported previously. [15] The spectral data are given here. 1H NMR: δ = 2.46 (m, 2 H), 3.22 (s, 3 H), 4.70 (dd, 1 H, J = 7.3, 4.9 Hz), 5.02 (m, 2 H), 5.86 (m, 1 H), 7.32 (m, 4 H). 13C NMR: (11 peaks): δ = 40.9, 56.9, 79.4, 116.9, 126.9, 127.2, 128.3, 129.3, 132.8, 134.3, 139.1.
-
19g
Compound 1g (Method D, 33%): this compound has been reported previously. [15] The spectral data are given here. 1H NMR: δ = 2.09 (s, 3 H), 2.54-2.62 (m, 2 H), 5.03-5.10 (t, 2 H, J = 6.18 Hz), 5.68-5.81 (m, 1 H), 6.18-6.23 (dd, 1 H, J = 7.7, 2.5 Hz), 7.19-7.41 (m, 4 H). 13C NMR (12 peaks): δ = 20.9, 39.4, 71.6, 118.1, 126.8, 127.1, 128.7, 129.5, 132.0, 132.9, 137.9, 169.7.
-
19h
Compound 1h (Method C, 35%): 1H NMR: δ = 2.50 (app t, 2 H), 4.38 (dd, 2 H), 4.91 (t, 1 H, J = 6.2 Hz), 5.02 (m, 1 H), 5.90 (dquar, 2 H), 7.30 (m, 9 H). 13C NMR (15 peaks): δ = 41.1, 70.9, 77.2, 117.0, 127.0, 127.5, 127.6, 127.7, 128.3, 128.4, 129.3, 132.9, 134.4, 138.2, 139.4. HRMS: m/e calcd for C17H17ClO: 272.0968 [M]; found: 271.0894 [M - 1].
-
19i
Compound 1i (Method A, 43%): 1H NMR: δ = 1.18 (t, 3 H, J = 7.18 Hz), 1.84 (s, 3 H), 2.26-2.42 (m, 2 H), 3.32-3.42 (m, 2 H), 4.78-4.85 (m, 3 H), 7.08-7.52 (m, 4 H). 13C (13 peaks): δ = 15.3, 22.9, 45.2, 64.6, 79.1, 112.4, 123.0, 127.6, 127.7, 128.6, 132.6, 142.1, 142.6. HRMS: m/e calcd for C13H17BrO: 268.0463 [M]; found: 267.0379 [M - 1].